Second consecutive win recognizes Hybrid Intelligence by Carta Healthcare as the winning approach to trustworthy clinical data abstraction Carta Healthcare, the award-winning leader in enterprise clinical data management, today announced more »
Carta Healthcare, the leader in enterprise clinical data management, today released findings from a national survey of U.S. healthcare leaders showing that AI is proving its worth but failing to more »
An early warning system for sepsis developed by Johns Hopkins University researchers was commercialized by Bayesian Health and cleared by the FDA. The software as a medical device (SaMD) more »
Adam Pellegrini, former CEO of Kaia Health and Jasper Health, is TytoCare’s new CEO, and Greg Orr, former VP of digital health at Walgreens, is the company’s new COO. TytoCare, more »
Following Accenture’s acquisition of Dragos and ServiceNow buying Armis, SJA hears exclusively from Asimily CEO Shankar Somasundarm about what the recent IoT/OT security consolidation means for the industry. Could you more »
Company Repositions as an AI-First Clinical Enablement Platform, Bringing FDA-Cleared AI-Powered Insights into Virtual Primary Care to Support Cardiopulmonary and Oncology Care TytoCare, pioneer of remote physical examination technology featuring more »
The pilot demonstrated significant cost savings by decreasing manual outbound calls and improving patient adherence to preparation protocols In March, Atlantic Health, a not-for-profit healthcare system caring for patients throughout New more »
Carta Healthcare, the leader in enterprise clinical data management, today announced Lighthouse for Oncology. Health systems can now apply Carta Healthcare’s Hybrid Intelligence approach to cancer registries, one of the more »
Clinical Expertise and Powerful AI Powers a New Era of Hybrid Intelligence in Healthcare Carta Healthcare, the leader in enterprise clinical data management, supporting more than 70 clinical registries, today more »
AristaMD announced the appointment of Julia Jezmir, MD, MBA, as President and Chief Medical Officer. The expanded leadership role supports the company’s next phase of growth and continued focus on more »
